FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3148004462> ?p ?o ?g. }

• W3148004462 endingPage "1132" @default.
• W3148004462 startingPage "1124" @default.
• W3148004462 abstract "We aimed to investigate risk factors for fatigue in patients with systemic lupus erythematosus (SLE) and neuropsychiatric symptoms in order to identify potential interventional strategies.Patients visiting the neuropsychiatric SLE (NPSLE) clinic of the Leiden University Medical Center between 2007-2019 were included. In a multidisciplinary consensus meeting, SLE patients were classified as having neuropsychiatric symptoms of inflammatory origin (inflammatory phenotype) or other origin (non-inflammatory phenotype). Fatigue was assessed with the SF-36 vitality domain (VT) since 2007 and the multidimensional fatigue inventory (MFI) and visual analogue scale (VAS) since 2011. Patients with a score on the SF-36 VT ≥1 standard deviation (SD) away from the mean of age-related controls of the general population were classified as fatigued; patients ≥2 SD away were classified as extremely fatigued. Disease activity was measured using the SLE disease activity index-2000. The influence of the presence of an inflammatory phenotype, disease activity and symptoms of depression and anxiety as measured by the hospital anxiety and depression scale (HADS) was analyzed using multiple regression analyses corrected for age, sex and education.348 out of 371 eligible patients filled in questionnaires and were included in this study . The majority was female (87%) and the mean age was 43 ± 14 years. 72 patients (21%) had neuropsychiatric symptoms of an inflammatory origin. Fatigue was present in 78% of all patients and extreme fatigue was present in 50% of patients with an inflammatory phenotype vs 46% in the non-inflammatory phenotype. Fatigue was similar in patients with an inflammatory phenotype compared to patients with a non-inflammatory phenotype on the SF-36 VT (β: 0.8 (95% CI -4.8; 6.1) and there was less fatigue in patients with an inflammatory phenotype on the MFI and VAS (β: -3.7 (95% CI: -6.9; -0.5) and β: -1.0 (95% CI -1.6; -0.3)). There was no association between disease activity and fatigue, but symptoms of anxiety and depression (HADS) associated strongly with all fatigue measurements.This study suggests that intervention strategies to target fatigue in (NP)SLE patients may need to focus on symptoms of anxiety and depression rather than immunosuppressive treatment." @default.
• W3148004462 created "2021-04-13" @default.
• W3148004462 creator A5010343802 @default.
• W3148004462 creator A5037097906 @default.
• W3148004462 creator A5041823391 @default.
• W3148004462 creator A5043817969 @default.
• W3148004462 creator A5045361419 @default.
• W3148004462 creator A5051357297 @default.
• W3148004462 creator A5054269152 @default.
• W3148004462 creator A5076382124 @default.
• W3148004462 creator A5078150048 @default.
• W3148004462 date "2021-03-28" @default.
• W3148004462 modified "2023-10-16" @default.
• W3148004462 title "Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity" @default.
• W3148004462 cites W1786220065 @default.
• W3148004462 cites W1919216911 @default.
• W3148004462 cites W1981956456 @default.
• W3148004462 cites W1994649501 @default.
• W3148004462 cites W2003239266 @default.
• W3148004462 cites W2037849916 @default.
• W3148004462 cites W2038983178 @default.
• W3148004462 cites W2041513052 @default.
• W3148004462 cites W2049033093 @default.
• W3148004462 cites W2073997771 @default.
• W3148004462 cites W2091881882 @default.
• W3148004462 cites W2095666655 @default.
• W3148004462 cites W2102471539 @default.
• W3148004462 cites W2107216509 @default.
• W3148004462 cites W2137873245 @default.
• W3148004462 cites W2150840378 @default.
• W3148004462 cites W2156540153 @default.
• W3148004462 cites W2166281097 @default.
• W3148004462 cites W2167383487 @default.
• W3148004462 cites W2255475147 @default.
• W3148004462 cites W2401528575 @default.
• W3148004462 cites W2561536790 @default.
• W3148004462 cites W2587880951 @default.
• W3148004462 cites W2606944526 @default.
• W3148004462 cites W2620741325 @default.
• W3148004462 cites W2808843415 @default.
• W3148004462 cites W2848189451 @default.
• W3148004462 cites W2905657133 @default.
• W3148004462 cites W2913730786 @default.
• W3148004462 cites W2963085910 @default.
• W3148004462 cites W2985474137 @default.
• W3148004462 cites W3010013932 @default.
• W3148004462 cites W3094324035 @default.
• W3148004462 cites W3111303015 @default.
• W3148004462 doi "https://doi.org/10.1177/09612033211005014" @default.
• W3148004462 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8120630" @default.
• W3148004462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33779389" @default.
• W3148004462 hasPublicationYear "2021" @default.
• W3148004462 type Work @default.
• W3148004462 sameAs 3148004462 @default.
• W3148004462 citedByCount "15" @default.
• W3148004462 countsByYear W31480044622021 @default.
• W3148004462 countsByYear W31480044622022 @default.
• W3148004462 countsByYear W31480044622023 @default.
• W3148004462 crossrefType "journal-article" @default.
• W3148004462 hasAuthorship W3148004462A5010343802 @default.
• W3148004462 hasAuthorship W3148004462A5037097906 @default.
• W3148004462 hasAuthorship W3148004462A5041823391 @default.
• W3148004462 hasAuthorship W3148004462A5043817969 @default.
• W3148004462 hasAuthorship W3148004462A5045361419 @default.
• W3148004462 hasAuthorship W3148004462A5051357297 @default.
• W3148004462 hasAuthorship W3148004462A5054269152 @default.
• W3148004462 hasAuthorship W3148004462A5076382124 @default.
• W3148004462 hasAuthorship W3148004462A5078150048 @default.
• W3148004462 hasBestOaLocation W31480044621 @default.
• W3148004462 hasConcept C118552586 @default.
• W3148004462 hasConcept C126322002 @default.
• W3148004462 hasConcept C139719470 @default.
• W3148004462 hasConcept C162324750 @default.
• W3148004462 hasConcept C1862650 @default.
• W3148004462 hasConcept C2776867660 @default.
• W3148004462 hasConcept C2776912625 @default.
• W3148004462 hasConcept C2778739829 @default.
• W3148004462 hasConcept C2779134260 @default.
• W3148004462 hasConcept C2908647359 @default.
• W3148004462 hasConcept C558461103 @default.
• W3148004462 hasConcept C71924100 @default.
• W3148004462 hasConcept C99454951 @default.
• W3148004462 hasConceptScore W3148004462C118552586 @default.
• W3148004462 hasConceptScore W3148004462C126322002 @default.
• W3148004462 hasConceptScore W3148004462C139719470 @default.
• W3148004462 hasConceptScore W3148004462C162324750 @default.
• W3148004462 hasConceptScore W3148004462C1862650 @default.
• W3148004462 hasConceptScore W3148004462C2776867660 @default.
• W3148004462 hasConceptScore W3148004462C2776912625 @default.
• W3148004462 hasConceptScore W3148004462C2778739829 @default.
• W3148004462 hasConceptScore W3148004462C2779134260 @default.
• W3148004462 hasConceptScore W3148004462C2908647359 @default.
• W3148004462 hasConceptScore W3148004462C558461103 @default.
• W3148004462 hasConceptScore W3148004462C71924100 @default.
• W3148004462 hasConceptScore W3148004462C99454951 @default.
• W3148004462 hasIssue "7" @default.
• W3148004462 hasLocation W31480044621 @default.
• W3148004462 hasLocation W31480044622 @default.

• next